| Organelle-specific initiation of cell death pathways | Nature Cell Biology | 2001 | 1.2K |
| Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming | Nature Medicine | 2001 | 1.1K |
| Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death | Nature | 2001 | 1.1K |
| The mitochondrion in apoptosis: how Pandora's box opens | Nature Reviews Molecular Cell Biology | 2001 | 840 |
| The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia | Blood | 2001 | 426 |
| Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group | Cancer | 2001 | 332 |
| NADH oxidase activity of mitochondrial apoptosis-inducing factor | Journal of Biological Chemistry | 2001 | 300 |
| Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2 | Journal of Experimental Medicine | 2001 | 242 |
| The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal | Oncogene | 2001 | 232 |
| Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology | Journal of Clinical Oncology | 2001 | 232 |
| Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group | Journal of Clinical Oncology | 2001 | 212 |
| Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor | FASEB Journal | 2001 | 210 |
| Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis | Oncogene | 2001 | 206 |
| Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study | Journal of Clinical Oncology | 2001 | 198 |
| Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors | Fertility and Sterility | 2001 | 183 |
| The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis | Blood | 2001 | 180 |
| Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours | European Journal of Cancer | 2001 | 177 |
| Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437 | Oncogene | 2001 | 174 |
| Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study) | British Journal of Cancer | 2001 | 164 |
| Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems | American Journal of Roentgenology | 2001 | 163 |
| Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors | Journal of Clinical Endocrinology and Metabolism | 2001 | 154 |
| Mitochondria--the suicide organelles | BioEssays | 2001 | 149 |
| Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors | Molecular Therapy | 2001 | 140 |
| Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity | Journal of Clinical Oncology | 2001 | 140 |
| Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study | Journal of the National Cancer Institute | 2001 | 139 |
